Flexible and Scalable Full-Length CYP2D6 Long Amplicon PacBio Sequencing

Human Mutation

Volumn 38, Issue 3, 2017, Pages 310-316

  Buermans, Henk P J ^a   Vossen, Rolf H A M ^a   Anvar, Seyed Yahya ^a   Allard, William G ^a   Guchelaar, Henk Jan ^a   White, Stefan J ^a   den Dunnen, Johan T ^a   Swen, Jesse J ^a   van der Straaten, Tahar ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

copy number variation; CYP2D6; PacBio long read sequencing; pharmacogenomics; variant phasing

Indexed keywords

CYTOCHROME P450 2D6;

AMPLICON; ARTICLE; COPY NUMBER VARIATION; GENE DELETION; GENE DUPLICATION; GENE SEQUENCE; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; INTRON; PRIORITY JOURNAL; PSEUDOGENE; SEQUENCE HOMOLOGY; DNA SEQUENCE; GENE TRANSLOCATION; GENETIC VARIATION; GENETICS; HUMAN;

CYTOCHROME P-450 CYP2D6; DNA COPY NUMBER VARIATIONS; GENE DELETION; GENE DUPLICATION; GENETIC VARIATION; GENOTYPE; HUMANS; SEQUENCE ANALYSIS, DNA; TRANSLOCATION, GENETIC;

EID: 85010781702     PISSN: 10597794     EISSN: 10981004     Source Type: Journal    
DOI: 10.1002/humu.23166     Document Type: Article

References (36)

1. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, Kondrashov AS, Sunyaev SR. 2010. A method and server for predicting damaging missense mutations. Nat Methods 7:248–249.
2. Ammar R, Paton TA, Torti D, Shlien A, Bader GD. 2015. Long read nanopore sequencing for detection of HLA and CYP2D6 variants and haplotypes. F1000Res 4:17.
3. Bank PCD, Swen JJ, Guchelaar H-J, van der Straaten T. 2015. GenoChip CYP2D6 macroarray as a method to genotype for CYP2D6 variants: results of a validation study in a Caucasian population. Pharmacogenomics 16:681–687.
4. Carneiro MO, Russ C, Ross MG, Gabriel SB, Nusbaum C, DePristo MA. 2012. Pacific biosciences sequencing technology for genotyping and variation discovery in human data. BMC Genomics 13:375.
5. Den Dunnen JT, Antonarakis SE. 2000. Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum Mutat 15:7–12.
6. De Leeneer K, Hellemans J, De Schrijver J, Baetens M, Poppe B, van Criekinge W, de Paepe A, Coucke P, Claes K. 2011. Massive parallel amplicon sequencing of the breast cancer genes BRCA1 and BRCA2: opportunities, challenges, and limitations. Hum Mutat 32:335–344.
7. Dezentjé VO, Opdam FL, Gelderblom H, Hartigh den J, van der Straaten T, Vree R, Maartense E, Smorenburg CH, Putter H, Dieudonné AS, Neven P, van de Velde CJH, et al. 2015. CYP2D6 genotype- and endoxifen-guided tamoxifen dose escalation increases endoxifen serum concentrations without increasing side effects. Breast Cancer Res Treat 153:583–590.
8. Drögemöller BI, Wright GEB, Niehaus DJH, Emsley R, Warnich L. 2013. Next-generation sequencing of pharmacogenes: a critical analysis focusing on schizophrenia treatment. Pharmacogenet Genomics 23:666–674.
9. Eichelbaum M, Spannbrucker N, Steincke B, Dengler HJ. 1979. Defective N-oxidation of sparteine in man: a new pharmacogenetic defect. Eur J Clin Pharmacol 16:183–187.
10. Fokkema IFAC, Taschner PEM, Schaafsma GCP, Celli J, Laros JFJ, den Dunnen JT. 2011. LOVD v.2.0: the next generation in gene variant databases. Hum Mutat 32:557–563.
11. Gaedigk A. 2013. Complexities of CYP2D6 gene analysis and interpretation. Int Rev Psychiatry 25:534–553.
12. Gaedigk A, Coetsee C. 2008. The CYP2D6 gene locus in South African Coloureds: unique allele distributions, novel alleles and gene arrangements. Eur J Clin Pharmacol 64:465–475.
13. Gaedigk A, Ndjountché L, Divakaran K, DiAnne Bradford L, Zineh I, Oberlander TF, Brousseau DC, McCarver DG, Johnson JA, Alander SW, Wayne Riggs K, Steven Leeder J. 2007. Cytochrome P4502D6 (CYP2D6) gene locus heterogeneity: characterization of gene duplication events. Clin Pharmacol Ther 81:242–251.
14. Gaedigk A, Simon SD, Pearce RE, Bradford LD, Kennedy MJ, Leeder JS. 2008. The CYP2D6 activity score: translating genotype information into a qualitative measure of phenotype. Clin Pharmacol Ther 83:234–242.
15. González-Pérez A, López-Bigas N. 2011. Improving the assessment of the outcome of nonsynonymous SNVs with a consensus deleteriousness score, Condel. Am J Hum Genet 88:440–449.
16. Hicks JK, Swen JJ, Gaedigk A. 2014. Challenges in CYP2D6 phenotype assignment from genotype data: a critical assessment and call for standardization. Curr Drug Metab 15:218–232.
17. Kalman LV, Agúndez J, Appell ML, Black JL, Bell GC, Boukouvala S, Bruckner C, Bruford E, Caudle K, Coulthard SA, Daly AK, del Tredici A, et al. 2016. Pharmacogenetic allele nomenclature: international workgroup recommendations for test result reporting. Clin Pharmacol Ther 99:172–185.
18. Kumar P, Henikoff S, Ng PC. 2009. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc 4:1073–1081.
19. Li H. 2011. A statistical framework for SNP calling, mutation discovery, association mapping and population genetical parameter estimation from sequencing data. Bioinformatics 27:2987–2993.
20. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, Marth G, Abecasis G, Durbin R, Subgroup 1000 Genome Project Data Processing. 2009. The sequence alignment/map format and SAMtools. Bioinformatics 25:2078–2079.
21. Mahgoub A, Dring LG, Idle JR, Lancaster R, Smith RL. 1977. Polymorphic hydroxylation of debrisoquine in man. Lancet 310:584–586.
22. Martin M. 2011. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet.journal 17:10–12.
23. McCarthy DJ, Humburg P, Kanapin A, Rivas MA, Gaulton K, Cazier J-B, Donnelly P. 2014. Choice of transcripts and software has a large effect on variant annotation. Genome Med 6:1–16.
24. Owen RP, Sangkuhl K, Klein TE, Altman RB. 2009. Cytochrome P450 2D6. Pharmacogenet Genomics 19:559–562.
25. Preissner S, Kroll K, Dunkel M, Senger C, Goldsobel G, Kuzman D, Guenther S, Winnenburg R, Schroeder M, Preissner R. 2010. SuperCYP: a comprehensive database on cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions. Nucleic Acids Res 38:D237–D243.
26. Qiao W, Yang Y, Sebra R, Mendiratta G, Gaedigk A, Desnick RJ, Scott SA. 2016. Long-read single molecule real-time full gene sequencing of cytochrome P450-2D6. Hum Mutat 37:315–323.
27. Rebsamen MC, Desmeules J, Daali Y, Chiappe A, Diemand A, Rey C, Chabert J, Dayer P, Hochstrasser D, Rossier MF. 2008. The AmpliChip CYP450 test: cytochrome P450 2D6 genotype assessment and phenotype prediction. Pharmacogenomics J 9:34–41.
28. Schenk PW, van Fessem MAC, Verploegh-Van Rij S, Mathot RAA, van Gelder T, Vulto AG, van Vliet M, Lindemans J, Bruijn JA, van Schaik RHN. 2007. Association of graded allele-specific changes in CYP2D6 function with imipramine dose requirement in a large group of depressed patients. Mol Psychiatry 13:597–605.
29. Sim SC, Ingelman-Sundberg M. 2010. The Human Cytochrome P450 (CYP) Allele Nomenclature website: a peer-reviewed database of CYP variants and their associated effects. Hum Genomics 4:278.
30. Sim SC, Ingelman-Sundberg M. 2013. Update on allele nomenclature for human cytochromes P450 and the Human Cytochrome P450 Allele (CYP-allele) Nomenclature Database. Methods Mol Biol 987:251–259.
31. The Netherlands Trial Register 1509. Accessed at: http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=1509.
32. Travers KJ, Chin C-S, Rank DR, Eid JS, Turner SW. 2010. A flexible and efficient template format for circular consensus sequencing and SNP detection. Nucleic Acids Res 38:e159–e159.
33. Twist GP, Gaedigk A, Miller NA, Farrow EG, Willig LK, Dinwiddie DL, Petrikin JE, Soden SE, Herd S, Gibson M, Cakici JA, Riffel AK, et al. 2016. Constellation: a tool for rapid, automated phenotype assignment of a highly polymorphic pharmacogene, CYP2D6, from whole-genome sequences. NPJ Genomic Med 1:15007.
34. Vairavan R. 2004. AutoGenomics, Inc. Pharmacogenomics 5:585–588.
35. Whirl-Carrillo M, McDonagh EM, Hebert JM, Gong L, Sangkuhl K, Thorn CF, Altman RB, Klein TE. 2012. Pharmacogenomics knowledge for personalized medicine. Clin Pharmacol Ther 92:414–417.
36. Wildeman M, van Ophuizen E, den Dunnen JT, Taschner PEM. 2008. Improving sequence variant descriptions in mutation databases and literature using the Mutalyzer sequence variation nomenclature checker. Hum Mutat 29:6–13.